Liver transplantation vs liver resection in patients with HBV‐related hepatocellular carcinoma beyond Milan criterion: A meta‐analysis

医学 米兰标准 肝细胞癌 肝移植 荟萃分析 内科学 危险系数 科克伦图书馆 置信区间 胃肠病学 子群分析 移植 肿瘤科 外科
作者
Wei Li,Long Li,Jun Han,Hong Wu
出处
期刊:Clinical transplantation [Wiley]
卷期号:32 (3) 被引量:8
标识
DOI:10.1111/ctr.13193
摘要

The aim of this study was to conduct a meta-analysis of published reports to compare long-term outcomes after liver transplantation (LT) and liver resection (LR), respectively, in patients with HBV-related hepatocellular carcinoma (HCC) beyond the Milan criterion.A systematic search of the Embase, Medline, PubMed databases, and the Cochrane Library was performed using both medical subject headings (MeSH) and truncated word searches to identify all comparative studies published on this topic. The primary outcomes were postoperative overall survival (OS) and disease-free survival (DFS). We calculated the pooled hazard ratios (HR) with 95% confidence intervals (95% CI) of OS and DFS.Pooled analysis of six studies, with a total of 1697 patients with HCC beyond Milan criteria, did not reveal a statistically significant improvement in OS in patients undergoing LT vs LR (LT vs LR, HR: 0.83, 95% CI: 0.68-1.01, P = .06), without significant heterogeneity (χ2 = 8.38, I2 = 40.3%, P = .137). Five studies with a total of 1511 patients were included in pooled analysis of DFS between LT and LR group. In the fixed-effects model, patients in the LT group gained significantly better DFS (LT vs LR, HR: 0.45, 95% CI: 0.37-0.56, P < .001) than patients in the LR group, with no significant heterogeneity (χ2 = 6.80, I2 = 41.6%, P = .144). Four studies provided the data of adjusted HRs (LT vs LR). In the fixed-effects model, patients in the LT group had significantly better OS (HR: 0.58, 95% CI: 0.44-0.77, P < .001, I2 = 0%) and DFS (HR: 0.14, 95% CI: 0.08-0.23, P < .001, I2 = 0%) than those of patients in the LR group. The sensitivity analyses revealed that the results were robust.Our meta-analysis demonstrated that HBV-related patients with HCC beyond Milan criterion who underwent LT gained better OS and DFS compared with patients who underwent LR after adjusting confounding factors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wanci的应助被smt采纳,获得10
刚刚
田様的应助被TT采纳,获得10
1秒前
pacify完成签到 ,获得积分10
1秒前
可爱的函函的应助被xiaoxuey采纳,获得10
2秒前
CipherSage的应助被精分的猫采纳,获得10
2秒前
Hello的应助被小马采纳,获得10
2秒前
kai发布了新的文献求助10
3秒前
4秒前
zxk完成签到,获得积分10
5秒前
王小明发布了新的文献求助10
5秒前
5秒前
tang发布了新的文献求助30
5秒前
搜集达人的应助被坚定的采波采纳,获得10
6秒前
7秒前
希望天下0贩的0的应助被春天采纳,获得10
7秒前
左一完成签到,获得积分10
7秒前
8秒前
思源的应助被yyy采纳,获得10
8秒前
tang发布了新的文献求助10
8秒前
芝士完成签到 ,获得积分10
9秒前
10秒前
田様的应助被Yoyo采纳,获得10
10秒前
kai完成签到,获得积分20
10秒前
QT完成签到,获得积分10
10秒前
大模型的应助被Rr采纳,获得10
12秒前
12秒前
zoeyluo的应助被Marciu33采纳,获得10
12秒前
搜集达人的应助被叉叉采纳,获得10
13秒前
我是老大的应助被巧克力采纳,获得10
14秒前
smt发布了新的文献求助10
16秒前
16秒前
u635689完成签到,获得积分10
16秒前
u496670完成签到,获得积分10
17秒前
17秒前
u473030完成签到,获得积分10
17秒前
u553408完成签到,获得积分10
17秒前
18秒前
18秒前
u522844完成签到,获得积分10
19秒前
ecchaos完成签到 ,获得积分10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184240
求助须知:如何正确求助?哪些是违规求助? 9573297
关于积分的说明 21830585
捐赠科研通 7781300
什么是DOI,文献DOI怎么找? 3434285
关于科研通互助平台的介绍 2558389
邀请新用户注册赠送积分活动 2480814